Literature DB >> 7601641

Abnormal activation and inactivation mechanisms of rod transduction in patients with autosomal dominant retinitis pigmentosa and the pro-23-his mutation.

D G Birch1, D C Hood, S Nusinowitz, D R Pepperberg.   

Abstract

PURPOSE: The leading edge of the rod a-wave in normal human subjects can be fit with a computational model of the activation phase of transduction to provide parameters analogous to those obtained from individual photoreceptors. The authors extend this work to the kinetics of recovery after saturating flashes.
METHODS: Electroretinograms were recorded from three patients with autosomal dominant retinitis pigmentosa and the pro-23-his rhodopsin mutation, two patients with rod monochromatism, and five normal subjects. Rod-only a-waves were obtained for a series of flashes ranging from 4.4 to 10.1 ln (1.9 to 4.4 log) scot td-sec. One set of parameters describing the activation process was derived from fits to the a-wave model. A double-flash paradigm was used to study inactivation mechanisms. The first flash was achromatic and varied in intensity (I(f)) from 6.1 to 13.9 ln (2.6 to 6.0 log) scot td-sec. The second flash was a short-wavelength probe held constant at 9.3 ln (4.0 log) scot td-sec. Cone components were elicited with a photopically matched long-wavelength stimulus and were computer subtracted. Recovery at each I(f) was followed by measuring the amplitude to the probe flash at various interstimulus intervals (ISI). The critical time (Tc) before the initiation of rod recovery was determined from the function relating relative rod amplitude to ISI.
RESULTS: Recovery from activation was similar in normal subjects and in patients with rod monochromatism. Over a large range of I(f) above rod saturation, Tc increased in proportion to ln I(f). The mean slope of the function relating Tc to I(f) was 2.3 s/ln I(f) when I(f) varied between 11 and 13.9 ln scot td-sec. Patients with retinitis pigmentosa and the pro-23-his rhodopsin mutation had a decrease in the gain of activation. They also had significantly slower than normal recovery after high test flash intensities, such that the slope of the function relating Tc to ln I(f) was 12.1 seconds.
CONCLUSION: Available data from other species imply that complete, transient activation of transducin (T saturation) occurs within or below the investigated range of flash intensities. Based on the slope of the delay function (delta Tc/ delta ln I(f)) above 11 ln scot td-sec, the authors hypothesize that the lifetime of activated rhodopsin (R) in normal human rods is approximately 2.3 seconds. In patients with the pro-23-his mutation, the gain of the activation mechanism is reduced and the reaction determining the delta Tc/ delta ln I(f) slope is markedly slowed. The activated species that exhibits this prolonged lifetime could be the mutant rhodopsin itself.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7601641

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  42 in total

1.  Electroretinographic determination of human rod flash response in vivo.

Authors:  D R Pepperberg; D G Birch; D C Hood
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  The interpretation of multifocal binary kernels.

Authors:  E Sutter
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

3.  Time course of the flash response of dark- and light-adapted human rod photoreceptors derived from the electroretinogram.

Authors:  C Friedburg; M M Thomas; T D Lamb
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

4.  Dynamic and steady-state light adaptation of mouse rod photoreceptors in vivo.

Authors:  G A Silva; J R Hetling; D R Pepperberg
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

5.  Excitation and desensitization of mouse rod photoreceptors in vivo following bright adapting light.

Authors:  Jennifer J Kang Derwent; Nasser M Qtaishat; David R Pepperberg
Journal:  J Physiol       Date:  2002-05-15       Impact factor: 5.182

Review 6.  An overview of drug development with special emphasis on the role of visual electrophysiological testing.

Authors:  Mitchell Brigell; Cun-Jian Dong; Serge Rosolen; Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

Review 7.  Light and inherited retinal degeneration.

Authors:  D M Paskowitz; M M LaVail; J L Duncan
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

8.  Flicker assessment of rod and cone function in a model of retinal degeneration.

Authors:  Glen R Rubin; Timothy W Kraft
Journal:  Doc Ophthalmol       Date:  2007-08-03       Impact factor: 2.379

9.  Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration.

Authors:  G Karan; C Lillo; Z Yang; D J Cameron; K G Locke; Y Zhao; S Thirumalaichary; C Li; D G Birch; H R Vollmer-Snarr; D S Williams; K Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-04       Impact factor: 11.205

10.  Guanylate cyclase-activating protein (GCAP) 1 rescues cone recovery kinetics in GCAP1/GCAP2 knockout mice.

Authors:  Mark E Pennesi; Kim A Howes; Wolfgang Baehr; Samuel M Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.